Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Crooks

Showing results (311-320 of 319) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 319 results.
JCSM Rapid Communications|April 12, 2021
Aging-associated skeletal muscle defects in HER2/Neu transgenic mammary tumor modelRuizhong Wang, Brijesh Kumar, Poornima Bhat-Nakshatri, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 28, 2009
Indolyl-quinuclidinols inhibit ENOX activity and endothelial cell morphogenesis while enhancing radiation-mediated control of tumor vasculatureLing Geng, Girish Rachakonda, D James Morré, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2011
The novel chemical entity YTR107 inhibits recruitment of nucleophosmin to sites of DNA damage, suppressing repair of DNA double-strand breaks and enhancing radiosensitizationKonjeti R Sekhar, Yerramreddy Thirupathi Reddy, Penthala Narsimha Reddy, et al.
Antimicrobial Agents and Chemotherapy|December 16, 2015
Novel Bone-Targeting Agent for Enhanced Delivery of Vancomycin to BoneZaineb A F Albayati, Manjula Sunkara, Suzannah M Schmidt-Malan, et al.
Scientific Reports|July 20, 2023
High flux novel polymeric membrane for renal applicationsChrista N Hestekin, Efecan Pakkaner, Jamie A Hestekin, et al.
The Journal of Biological Chemistry|August 31, 2016
Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem CellsShanshan Pei, Mohammad Minhajuddin, Angelo D'Alessandro, et al.
Blood|September 7, 2007
An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cellsMonica L Guzman, Randall M Rossi, Sundar Neelakantan, et al.
The Journal of Biological Chemistry|October 4, 2013
Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cellsShanshan Pei, Mohammad Minhajuddin, Kevin P Callahan, et al.
ACS Central Science|January 17, 2019
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological SpaceSara E Kearney, Gergely Zahoránszky-Kőhalmi, Kyle R Brimacombe, et al.
Pageof 32

Showing results (311-320 of 319) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 319 results.
JCSM Rapid Communications|April 12, 2021
Aging-associated skeletal muscle defects in HER2/Neu transgenic mammary tumor modelRuizhong Wang, Brijesh Kumar, Poornima Bhat-Nakshatri, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 28, 2009
Indolyl-quinuclidinols inhibit ENOX activity and endothelial cell morphogenesis while enhancing radiation-mediated control of tumor vasculatureLing Geng, Girish Rachakonda, D James Morré, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2011
The novel chemical entity YTR107 inhibits recruitment of nucleophosmin to sites of DNA damage, suppressing repair of DNA double-strand breaks and enhancing radiosensitizationKonjeti R Sekhar, Yerramreddy Thirupathi Reddy, Penthala Narsimha Reddy, et al.
Antimicrobial Agents and Chemotherapy|December 16, 2015
Novel Bone-Targeting Agent for Enhanced Delivery of Vancomycin to BoneZaineb A F Albayati, Manjula Sunkara, Suzannah M Schmidt-Malan, et al.
Scientific Reports|July 20, 2023
High flux novel polymeric membrane for renal applicationsChrista N Hestekin, Efecan Pakkaner, Jamie A Hestekin, et al.
The Journal of Biological Chemistry|August 31, 2016
Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem CellsShanshan Pei, Mohammad Minhajuddin, Angelo D'Alessandro, et al.
Blood|September 7, 2007
An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cellsMonica L Guzman, Randall M Rossi, Sundar Neelakantan, et al.
The Journal of Biological Chemistry|October 4, 2013
Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cellsShanshan Pei, Mohammad Minhajuddin, Kevin P Callahan, et al.
ACS Central Science|January 17, 2019
Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological SpaceSara E Kearney, Gergely Zahoránszky-Kőhalmi, Kyle R Brimacombe, et al.
Pageof 32